Skip to main content

Table 4 Top biological processes and KEEG pathways connected to the MAGEL2 mutation and SNORD116 deletion

From: Patients with PWS and related syndromes display differentially methylated regions involved in neurodevelopmental and nutritional trajectory

MAGEL2

Cellular macromolecule biosynthetic process

GO:0034645

2.83E−07

 

Macromolecule biosynthetic process

GO:0009059

7.87E−07

 

Organic substance biosynthetic process

GO:1901576

3.08E−06

 

Biosynthetic process

GO:0009058

4.21E−06

 

Cellular biosynthetic process

GO:0044249

9.83E−06

 

Regulation of RNA metabolic process

GO:0051252

5.03E−05

 

Nucleobase-containing compound metabolic process

GO:0006139

6.72E−05

 

Nucleic acid metabolic process

GO:0090304

8.69E−05

SNORD116

Cellular metabolic process

GO:0044237

8.54E−09

Nervous system development

GO:0007399

9.56E−09

Metabolic process

GO:0008152

6.57E−08

Primary metabolic process

GO:0044238

3.31E−07

Nitrogen compound metabolic process

GO:0006807

5.41E−07

Nucleic acid metabolic process

GO:0090304

9.97E−07

Organic substance metabolic process

GO:0071704

1.15E−06

Central nervous system development

GO:0007417

1.34E−06

Hippo signaling pathway

KEGG:04390

6.29E−03

Chronic myeloid leukemia

KEGG:05220

1.25E−02

Neurotrophin signaling pathway

KEGG:04722

4.77E−02